Type 1 DM: Islet transplantation! Flashcards

1
Q

Define allotransplantation

A

between individuals of the same species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define autologous transplantation

A

same individual ‘here you go me, a present from me’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define syngeneic transplants

A

genetically identical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define xenotransplantation

A

different species -porcine islets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the current situation with islant transplantation?

A

in 2k1 we though woah son, in 10 years time islet transplantations gonna b all the rage wat, but then 2010 rolled around and just like hoverboards islet transplantation was nowhere to be found we are rUINING THE FUTURE GUYS. most people who do manage god knows how to get a transplantation return to near full insulin replacement within 5 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many UK centres are currently performing transplants?

A

9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are NINE problems with islet transplantation?

A

1) islet yield 2) islet stress 3)non-specific intra-islet inflammation 4)blood mediated inflammatory reponse 5)glucotoxicity 6)host rejection 7)immunosuppressant 8)revascularisation 9)recurrence of autoimmunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Obstacle: loss of islet cell viability during isolation

A

Approach: improved extraction and culture conditions (normoxic conditions, growth factor supplementation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Obstacle: revascularisation of transplanted tissues

A

Approach: growth factor supplementation, gene based approaches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

obstacle: host induced inflammation, recurrence of auto immunit and non-specific intra islet inflammation

A

approach: drug targets, gene based approaches and encapsulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

obstacle: poor islet cell mass aquired for transplant

A

approach: increase beta cell proliferation in transplanted tissues, donor availability and improved survival/retention of grafted tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Prob with using pig islets

A

zoonotic infection and immunological barriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

probs with cellular reprogramming

A

feasibility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

probs with cadaveric islets

A

limited supply and quality control difficult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

probs with embryonic stem cells

A

ethics and teratogenic potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

probs wtih induced pluripotent stem cell

A

transcription factor induced transformation means teratogenic potential

17
Q

How many donors are required for transplantation?

A

up to 4

18
Q

immediate cell loss?

A

up to 70% within days

19
Q

Intra-hepatic via portal vein as transplantation site:

A

high success rate, has a near optimal O2 tension and avoids systemic hyperinsulinaemia. BUT inflammatory response so immunosuppresent levels :/ difficult to biopsy

20
Q

alternative sites for transplant?

A

kidney capsule, anterior eye chamber, subcutaneous, intramuscular and intrapancreatic

21
Q

IBMR?

A

Instant blood-mediated inflammatory reponse, a non-specific innate response that leads to massive early cell loss. coagulation system/complement so drug targetss?

22
Q

Caspase inhibition as a drug target?

A

IDN-6556, oral admin, improved safety, improves early survival in models. improves glucose tolerance 1 month after transplantation and improved insulin content

23
Q

IDN-6556?

A

CASPASE INHIBITOR SON

24
Q

what reduced apop after 24 hrs?

A

IDN-6556

25
Q

What is another inhibitor of apoptosis?

A

Casp-3 siRNA - reduces casp 3 expression in human cells.

26
Q

What are 4 gene based approaches to help grafts?

A

1) over expressing a gene to promote engraftment 2) over expressing genes to prevent cell loss 3) expressing a construct to silence expression of pro-apop genes 4)construction of bipartite vectors

27
Q

What are 3 types of artificial pancreas?

A

1) micro-encapsulation 2)macro encapsulation 3) blood perfusion type

28
Q

What is good about encapsulation?

A

negates host rejection and prevents recurrent auto-immunity

29
Q

What is microencapsulation in alginate?

A

additional surface ‘coats’ to modify proteins. variable islet volume a problem, as is incomplete encapsulation and the fact it can increase fibrosis.

30
Q

Why is cell surface coating awesome?

A

pretty much total immune evasion.

31
Q

What are 3 pitfalls of encapsulation?

A

1)biocompatibility leads to fibrosis plus theres the innate immune system 2)immune response from small molecule permeability 3)hypoxia; capsule limits revascularisation, needs tons of islets and hypoxia makes the other 2 worse